Charles Li enjoys translation and commercialization of innovative biotechnologies to make the world a healthier place. Charles is a former research scientist with fifteen years of experience in pharmaceutical research and development, his scientific expertise includes medicinal chemistry in cancer and neurodegenerative diseases, imaging probe development for biomedical research and clinical diagnosis. Charles' recent focus is on hiPSC products for CNS drug discovery and cell therapy. Charles has founded and helped several very early stage life science companies in the US and China during the past four years.